Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04476992Phase 1Completed

Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement

Role: collaborator

NCT05354648Not ApplicableCompleted

Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients

Role: collaborator

NCT03855046Phase 4Recruiting

Complex Treatment of a Chronic Anal Fissure

Role: collaborator

All 3 trials loaded